- Open Access
Correction to: Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
Journal of Translational Medicine volume 19, Article number: 414 (2021)
Correction to: J Transl Med (2019) 17:100 https://doi.org/10.1186/s12967-019-1829-z
The authors declare that a patent application entitled “Cell-based vehicles for potentiation of viral therapy” has been filed on August 8, 2019 by the inventors Dobrin Draganov and Aladar A. Szalay .
Draganov DD, Santidrian A, Minev I, et al. Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers. J Transl Med. 2019;17:100. https://doi.org/10.1186/s12967-019-1829-z.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Draganov, D.D., Santidrian, A.F., Minev, I. et al. Correction to: Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers. J Transl Med 19, 414 (2021). https://doi.org/10.1186/s12967-021-02866-7